Is Zepbound FDA Approved?
DrugStatusIndex provides a clear, data-driven view of the regulatory status of medications, compounds, and related products. Each entry is based on publicly available information from the U.S. Food and Drug Administration and other authoritative sources. This page explains whether Zepbound is FDA approved and how it is commonly categorized.
Overview
Zepbound is a brand-name medication containing tirzepatide. It is used as an FDA-approved product for chronic weight management in certain adults when used according to its approved labeling.
FDA Status Details
Zepbound is classified as FDA Approved for specific approved indications and dosage forms. Approval status depends on the product being the FDA-approved Zepbound product, not a compounded or privately marketed tirzepatide version.
Brand Names & Variants
Zepbound is a brand-name tirzepatide product. Tirzepatide is also associated with Mounjaro, a separate FDA-approved brand-name product with a different approved use profile.
Compounded & Private Label Considerations
Compounded tirzepatide products are not FDA-approved drugs. Products marketed as compounded, private-label, research-use, or online alternatives to Zepbound should not be treated as FDA-approved Zepbound equivalents.
Search Another Drug or Compound
Use DrugStatusIndex to review public regulatory status information for medications, compounds, and related products.